Researchers Identify Drugs with Fewest Side-Effects for Treating Irritable Bowel Syndrome

Cedars-Sinai researchers have determined that two prevalent drug therapies - rifaximin and lubiprostone - offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans. The findings, based on an analysis of more than two dozen large-scale clinical trials, are contained in a peer-reviewed study published online by The American Journal of Medicine and set to appear in the publication's April print edition.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews